NR4A1 and triple-negative breast carcinoma: This study investigates the effects of the ruthenium complex Bis(quinolin-8-olato)bis(triphenylphosphine)ruthenium(II) (Ru(quin)2) in hormone receptor-positive and triple-negative breast cancer cell models.